- recruitingPHASE3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
This study is testing a new medicine called nipocalimab for adults with a muscle weakness condition called generalised myasthenia gravis (gMG). Researchers want to see if it's safe and helps improve symptoms compared to a dummy treatment. They are also looking at different ways to give the medicine.
United States · Australia · Belgium - active not recruitingPHASE1
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
This study is looking at a new drug called CC-97540 for people with certain types of Multiple Sclerosis (MS) or a muscle weakness condition called Myasthenia Gravis (MG). We want to see if it's safe, how well people can handle it, and if it helps their condition.
United States · Belgium · France - recruitingNA
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
This study is testing a new smartphone app for people with Myasthenia Gravis (MG). The app helps monitor MG symptoms like weakness and breathing at home. We want to see if it's as good as tests done in a clinic and if it's easy and safe to use.
United States · France - enrolling by invitation
Prevalence and Impact of Fatigue in Myasthenic Patients Followed At Clermont-Ferrand University Hospital - "My" Asthenia
This study at Clermont-Ferrand University Hospital in France is looking at how tired people with myasthenia gravis feel. Researchers want to understand fatigue better by asking patients to fill out questionnaires and looking at their medical records.
France - active not recruitingPHASE3
A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis
This study is testing a new medicine called efgartigimod for people with a type of Myasthenia Gravis (MG). It checks how well it works and if it's safe compared to a dummy medicine. Some people will then get the new medicine openly.
United States · Belgium · Canada - recruiting
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
This study looks at the safety of a new medicine called efgartigimod for people with myasthenia gravis (gMG). Researchers are observing patients as they take the medicine in their everyday lives to understand its effects.
United States · Austria · Belgium - recruitingPHASE2, PHASE3
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
This study is testing a new cell therapy called KYV-101 for people with a type of muscle weakness called myasthenia gravis. It aims to see if this therapy, which targets specific immune cells, can help reduce symptoms and improve daily life for patients.
United States · Australia · Brazil - recruiting
Vitaccess Real MG Registry
This study looks at how myasthenia gravis (MG) affects daily life and how treatments work over 10 years. It gathers information from patients and their doctors about symptoms, daily activities, and quality of life to help us understand MG better.
United States · United Kingdom